
Sign up to save your podcasts
Or


In this episode, Professor Rory O’Connor and Craig spoke to Edmond J. Safra Professor of Neuropsychopharmacology and the head of the Psychedelics Research Centre at Imperial College London, Professor David Nutt.
David specialises in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Currently, David is investigating if psychedelic drugs can be effective against treatment-resistant depression.
In this conversation, they discussed the stigma around drugs, alternative treatments for mental health issues, and why openness is important in research and innovation.
By MQ Mental Health Research4
22 ratings
In this episode, Professor Rory O’Connor and Craig spoke to Edmond J. Safra Professor of Neuropsychopharmacology and the head of the Psychedelics Research Centre at Imperial College London, Professor David Nutt.
David specialises in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Currently, David is investigating if psychedelic drugs can be effective against treatment-resistant depression.
In this conversation, they discussed the stigma around drugs, alternative treatments for mental health issues, and why openness is important in research and innovation.

90 Listeners

65 Listeners

2,509 Listeners

613 Listeners

99,378 Listeners

678 Listeners

99 Listeners

2,852 Listeners

2,068 Listeners

103 Listeners

41 Listeners